Do analysts rate PCSC or EBS?

Emergent Biosolutions has a consensus target price of $10.00, suggesting a potential upside of 119.54%. Given Emergent Biosolutions' stronger consensus rating and higher possible upside, analysts plainly believe Emergent Biosolutions is more favorable than Perceptive Capital Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perceptive Capital Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Emergent Biosolutions 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Do analysts recommend PCSC or ABEO?

Abeona Therapeutics has a consensus target price of $19.00, indicating a potential upside of 164.44%. Given Abeona Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Abeona Therapeutics is more favorable than Perceptive Capital Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perceptive Capital Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Abeona Therapeutics 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Is PCSC or ABEO more profitable?

Perceptive Capital Solutions' return on equity of -2.70% beat Abeona Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Perceptive Capital Solutions N/A -2.70% -0.84% Abeona Therapeutics N/A -53.98% -38.52%

Do analysts prefer RCKT or PCSC?

Rocket Pharmaceuticals presently has a consensus target price of $8.71, indicating a potential upside of 138.42%. Given Rocket Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe Rocket Pharmaceuticals is more favorable than Perceptive Capital Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rocket Pharmaceuticals 3 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.30 Perceptive Capital Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, RCKT or PCSC?

Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rocket Pharmaceuticals N/A N/A -$223.12M -$1.87 N/A Perceptive Capital Solutions N/A N/A $840K -$0.06 N/A

Is RCKT or PCSC more profitable?

Perceptive Capital Solutions' return on equity of -2.70% beat Rocket Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Rocket Pharmaceuticals N/A -69.61% -58.63% Perceptive Capital Solutions N/A -2.70% -0.84%

Do analysts prefer PCSC or ELYM?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perceptive Capital Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Eliem Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation & earnings, PCSC or ELYM?

Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Eliem Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Perceptive Capital Solutions N/A N/A $840K -$0.06 N/A Eliem Therapeutics N/A N/A -$35.12M -$0.53 N/A

Is PCSC or ELYM more profitable?

Perceptive Capital Solutions' return on equity of -2.70% beat Eliem Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Perceptive Capital Solutions N/A -2.70% -0.84% Eliem Therapeutics N/A -47.03% -45.97%

Do analysts recommend PCSC or UPB?

Upstream Bio has a consensus price target of $33.17, indicating a potential upside of 346.45%. Given Upstream Bio's stronger consensus rating and higher probable upside, analysts plainly believe Upstream Bio is more favorable than Perceptive Capital Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perceptive Capital Solutions 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Upstream Bio 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Perceptive Capital Solutions (PCSC) Competitors

$11.95 0.00 (0.00%)

As of 07/21/2026

Compare

PCSC vs. EBS, ABEO, RCKT, ELYM, and UPB

Should you buy Perceptive Capital Solutions stock or one of its competitors? MarketBeat compares Perceptive Capital Solutions with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Perceptive Capital Solutions include Emergent Biosolutions (EBS), Abeona Therapeutics (ABEO), Rocket Pharmaceuticals (RCKT), Eliem Therapeutics (ELYM), and Upstream Bio (UPB). These companies are all part of the "biotechnology" industry.

How does Perceptive Capital Solutions compare to Emergent Biosolutions?

Perceptive Capital Solutions (NASDAQ:PCSC) and Emergent Biosolutions (NYSE:EBS) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Perceptive Capital Solutions has a net margin of 0.00% compared to Emergent Biosolutions' net margin of -22.95%. Emergent Biosolutions' return on equity of 16.35% beat Perceptive Capital Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perceptive Capital Solutions	N/A	-2.70%	-0.84%
Emergent Biosolutions	-22.95%	16.35%	6.17%

Perceptive Capital Solutions has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, Emergent Biosolutions has a beta of 2.35, meaning that its stock price is 135% more volatile than the broader market.

Emergent Biosolutions has a consensus target price of $10.00, suggesting a potential upside of 119.54%. Given Emergent Biosolutions' stronger consensus rating and higher possible upside, analysts plainly believe Emergent Biosolutions is more favorable than Perceptive Capital Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perceptive Capital Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Emergent Biosolutions	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Emergent Biosolutions has higher revenue and earnings than Perceptive Capital Solutions. Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Emergent Biosolutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perceptive Capital Solutions	N/A	N/A	$840K	-$0.06	N/A
Emergent Biosolutions	$742.30M	0.32	$52.60M	-$3.55	N/A

In the previous week, Emergent Biosolutions had 18 more articles in the media than Perceptive Capital Solutions. MarketBeat recorded 18 mentions for Emergent Biosolutions and 0 mentions for Perceptive Capital Solutions. Emergent Biosolutions' average media sentiment score of 0.43 beat Perceptive Capital Solutions' score of 0.00 indicating that Emergent Biosolutions is being referred to more favorably in the news media.

Company	Overall Sentiment
Perceptive Capital Solutions	Neutral
Emergent Biosolutions	Neutral

78.4% of Emergent Biosolutions shares are held by institutional investors. 22.1% of Perceptive Capital Solutions shares are held by company insiders. Comparatively, 6.0% of Emergent Biosolutions shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Emergent Biosolutions beats Perceptive Capital Solutions on 12 of the 15 factors compared between the two stocks.

How does Perceptive Capital Solutions compare to Abeona Therapeutics?

Perceptive Capital Solutions (NASDAQ:PCSC) and Abeona Therapeutics (NASDAQ:ABEO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Abeona Therapeutics has a consensus target price of $19.00, indicating a potential upside of 164.44%. Given Abeona Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Abeona Therapeutics is more favorable than Perceptive Capital Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perceptive Capital Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Abeona Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Abeona Therapeutics had 4 more articles in the media than Perceptive Capital Solutions. MarketBeat recorded 4 mentions for Abeona Therapeutics and 0 mentions for Perceptive Capital Solutions. Perceptive Capital Solutions' average media sentiment score of 0.00 equaled Abeona Therapeutics'average media sentiment score.

Company	Overall Sentiment
Perceptive Capital Solutions	Neutral
Abeona Therapeutics	Neutral

Perceptive Capital Solutions' return on equity of -2.70% beat Abeona Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perceptive Capital Solutions	N/A	-2.70%	-0.84%
Abeona Therapeutics	N/A	-53.98%	-38.52%

Abeona Therapeutics has higher revenue and earnings than Perceptive Capital Solutions. Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perceptive Capital Solutions	N/A	N/A	$840K	-$0.06	N/A
Abeona Therapeutics	$5.82M	70.36	$71.18M	$0.97	7.41

Perceptive Capital Solutions has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Abeona Therapeutics has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

80.6% of Abeona Therapeutics shares are held by institutional investors. 22.1% of Perceptive Capital Solutions shares are held by company insiders. Comparatively, 7.1% of Abeona Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Abeona Therapeutics beats Perceptive Capital Solutions on 10 of the 13 factors compared between the two stocks.

How does Perceptive Capital Solutions compare to Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ:RCKT) and Perceptive Capital Solutions (NASDAQ:PCSC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Perceptive Capital Solutions' return on equity of -2.70% beat Rocket Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket Pharmaceuticals	N/A	-69.61%	-58.63%
Perceptive Capital Solutions	N/A	-2.70%	-0.84%

Rocket Pharmaceuticals has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market. Comparatively, Perceptive Capital Solutions has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market.

In the previous week, Rocket Pharmaceuticals had 3 more articles in the media than Perceptive Capital Solutions. MarketBeat recorded 3 mentions for Rocket Pharmaceuticals and 0 mentions for Perceptive Capital Solutions. Rocket Pharmaceuticals' average media sentiment score of 0.34 beat Perceptive Capital Solutions' score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Rocket Pharmaceuticals	Neutral
Perceptive Capital Solutions	Neutral

Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Rocket Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket Pharmaceuticals	N/A	N/A	-$223.12M	-$1.87	N/A
Perceptive Capital Solutions	N/A	N/A	$840K	-$0.06	N/A

Rocket Pharmaceuticals presently has a consensus target price of $8.71, indicating a potential upside of 138.42%. Given Rocket Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe Rocket Pharmaceuticals is more favorable than Perceptive Capital Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket Pharmaceuticals	3 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.30
Perceptive Capital Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

98.4% of Rocket Pharmaceuticals shares are owned by institutional investors. 21.3% of Rocket Pharmaceuticals shares are owned by insiders. Comparatively, 22.1% of Perceptive Capital Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Rocket Pharmaceuticals beats Perceptive Capital Solutions on 9 of the 14 factors compared between the two stocks.

How does Perceptive Capital Solutions compare to Eliem Therapeutics?

Perceptive Capital Solutions (NASDAQ:PCSC) and Eliem Therapeutics (NASDAQ:ELYM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Perceptive Capital Solutions' average media sentiment score of 0.00 equaled Eliem Therapeutics'average media sentiment score.

Company	Overall Sentiment
Perceptive Capital Solutions	Neutral
Eliem Therapeutics	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perceptive Capital Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Eliem Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Eliem Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perceptive Capital Solutions	N/A	N/A	$840K	-$0.06	N/A
Eliem Therapeutics	N/A	N/A	-$35.12M	-$0.53	N/A

Perceptive Capital Solutions' return on equity of -2.70% beat Eliem Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perceptive Capital Solutions	N/A	-2.70%	-0.84%
Eliem Therapeutics	N/A	-47.03%	-45.97%

69.8% of Eliem Therapeutics shares are owned by institutional investors. 22.1% of Perceptive Capital Solutions shares are owned by company insiders. Comparatively, 4.7% of Eliem Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Perceptive Capital Solutions has a beta of 0.36, meaning that its share price is 64% less volatile than the broader market. Comparatively, Eliem Therapeutics has a beta of -0.39, meaning that its share price is 139% less volatile than the broader market.

Summary

Perceptive Capital Solutions beats Eliem Therapeutics on 7 of the 9 factors compared between the two stocks.

How does Perceptive Capital Solutions compare to Upstream Bio?

Perceptive Capital Solutions (NASDAQ:PCSC) and Upstream Bio (NASDAQ:UPB) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

Upstream Bio has a consensus price target of $33.17, indicating a potential upside of 346.45%. Given Upstream Bio's stronger consensus rating and higher probable upside, analysts plainly believe Upstream Bio is more favorable than Perceptive Capital Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Perceptive Capital Solutions	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Upstream Bio	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Perceptive Capital Solutions has a beta of 0.36, indicating that its share price is 64% less volatile than the broader market. Comparatively, Upstream Bio has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Perceptive Capital Solutions has a net margin of 0.00% compared to Upstream Bio's net margin of -4,718.96%. Perceptive Capital Solutions' return on equity of -2.70% beat Upstream Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Perceptive Capital Solutions	N/A	-2.70%	-0.84%
Upstream Bio	-4,718.96%	-43.82%	-42.27%

Perceptive Capital Solutions has higher earnings, but lower revenue than Upstream Bio. Perceptive Capital Solutions is trading at a lower price-to-earnings ratio than Upstream Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Perceptive Capital Solutions	N/A	N/A	$840K	-$0.06	N/A
Upstream Bio	$3.32M	121.70	-$143.44M	-$2.91	N/A

In the previous week, Upstream Bio had 2 more articles in the media than Perceptive Capital Solutions. MarketBeat recorded 2 mentions for Upstream Bio and 0 mentions for Perceptive Capital Solutions. Upstream Bio's average media sentiment score of 0.60 beat Perceptive Capital Solutions' score of 0.00 indicating that Upstream Bio is being referred to more favorably in the news media.

Company	Overall Sentiment
Perceptive Capital Solutions	Neutral
Upstream Bio	Positive

Summary

Upstream Bio beats Perceptive Capital Solutions on 8 of the 13 factors compared between the two stocks.

Get Perceptive Capital Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PCSC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PCSC vs. The Competition

Export

Metric	Perceptive Capital Solutions	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$97.48M	$3.71B	$7.03B	$12.96B
Dividend Yield	N/A	3.76%	2.58%	10.20%
P/E Ratio	-199.13	9.06	269.91	24.87
Price / Sales	N/A	1,278.42	654.69	108.21
Price / Cash	127.23	44.95	28.89	37.44
Price / Book	-15.52	17.97	11.40	6.45
Net Income	$840K	-$13.25M	$3.45B	$347.50M
7 Day Performance	N/A	5.58%	3.66%	3.77%
1 Month Performance	10.65%	-1.60%	-0.49%	-0.40%
1 Year Performance	-9.23%	61.32%	77.51%	23.55%

Perceptive Capital Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PCSC Perceptive Capital Solutions	0.1188 of 5 stars	$11.95 flat	N/A	N/A	$97.48M	N/A	N/A	N/A
EBS Emergent Biosolutions	2.281 of 5 stars	$5.31 -29.6%	$12.00 +126.0%	-43.3%	$389.03M	$742.30M	N/A	2,420	Earnings Report Analyst Forecast Gap Down High Trading Volume
ABEO Abeona Therapeutics	3.0189 of 5 stars	$6.90 +1.5%	$19.00 +175.4%	+15.7%	$387.57M	$5.82M	7.11	90	Upcoming Earnings Gap Down
RCKT Rocket Pharmaceuticals	2.569 of 5 stars	$3.54 +1.1%	$8.71 +146.2%	+26.2%	$382.18M	N/A	N/A	240	News Coverage Analyst Downgrade
ELYM Eliem Therapeutics	N/A	$12.47 -0.7%	N/A	+723.5%	$371.01M	N/A	N/A	9	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PCSC) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Perceptive Capital Solutions (PCSC) Competitors

PCSC vs. EBS, ABEO, RCKT, ELYM, and UPB

How does Perceptive Capital Solutions compare to Emergent Biosolutions?

Summary

How does Perceptive Capital Solutions compare to Abeona Therapeutics?

Summary

How does Perceptive Capital Solutions compare to Rocket Pharmaceuticals?

Summary

How does Perceptive Capital Solutions compare to Eliem Therapeutics?

Summary

How does Perceptive Capital Solutions compare to Upstream Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PCSC vs. The Competition

Perceptive Capital Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Perceptive Capital Solutions (PCSC) Competitors

PCSC vs. EBS, ABEO, RCKT, ELYM, and UPB

How does Perceptive Capital Solutions compare to Emergent Biosolutions?

Is PCSC or EBS more profitable?

Which has more risk & volatility, PCSC or EBS?

Do analysts rate PCSC or EBS?

Which has higher earnings & valuation, PCSC or EBS?

Does the media prefer PCSC or EBS?

Do institutionals & insiders hold more shares of PCSC or EBS?

Summary

How does Perceptive Capital Solutions compare to Abeona Therapeutics?

Do analysts recommend PCSC or ABEO?

Does the media prefer PCSC or ABEO?

Is PCSC or ABEO more profitable?

Which has preferable valuation & earnings, PCSC or ABEO?

Which has more risk & volatility, PCSC or ABEO?

Do institutionals and insiders believe in PCSC or ABEO?

Summary

How does Perceptive Capital Solutions compare to Rocket Pharmaceuticals?

Is RCKT or PCSC more profitable?

Which has more volatility and risk, RCKT or PCSC?

Does the media refer more to RCKT or PCSC?

Which has preferable valuation and earnings, RCKT or PCSC?

Do analysts prefer RCKT or PCSC?

Do institutionals and insiders believe in RCKT or PCSC?

Summary

How does Perceptive Capital Solutions compare to Eliem Therapeutics?

Does the media refer more to PCSC or ELYM?

Do analysts prefer PCSC or ELYM?

Which has better valuation & earnings, PCSC or ELYM?

Is PCSC or ELYM more profitable?

Do insiders & institutionals believe in PCSC or ELYM?

Which has more risk and volatility, PCSC or ELYM?

Summary

How does Perceptive Capital Solutions compare to Upstream Bio?

Do analysts recommend PCSC or UPB?

Which has more volatility & risk, PCSC or UPB?

Is PCSC or UPB more profitable?

Which has stronger earnings and valuation, PCSC or UPB?

Does the media favor PCSC or UPB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PCSC vs. The Competition

Perceptive Capital Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools